Credent Connect N Care (NSE: CREDENT) is a New Delhi, Delhi-based company in the Medical Testing, Analyzing, and Diagnostic Equipment industry. With a market capitalisation of ₹595 Cr, it ranks #1,869 by market cap among the 6,189 Indian listed companies on FinBizNet, and #3 of 7 in Medical Testing, Analyzing, and Diagnostic Equipment. At ₹326.55 (as of 28 Oct 2026), the share price is 17.0% below its 52-week high of ₹393.45 and -12.9% above its 52-week low of ₹375.00.
| Current Price | ₹326.55 |
|---|---|
| Market Cap | ₹595 Cr |
| NSE Symbol | CREDENT |
| Sector | Health Care > Health Care Equipment and Services > Health Care Equipment and Supplies |
| Sub-Industry | Health Care Equipment > Medical Testing, Analyzing, and Diagnostic Equipment |
| P/E Ratio | 23.4 |
| Return on Assets | 28.93% |
| 52-Week Range | ₹375.00 – ₹393.45 |
| Beta (1Y) | 2.14 |
| Headquarters | New Delhi, Delhi |
| Website | c3logistics.co.in |
Credent Connect N Care Limited operates as a healthcare services provider engaged in delivering integrated logistics, workforce solutions, and technology-enabled support to healthcare institutions in India. The company provides comprehensive operational and logistics services to diagnostic laboratories, In Vitro Diagnostics (IVD) companies, pharmaceutical companies, clinics, and other healthcare enterprises. Its services include home sample collection through trained phlebotomists; Operations & Supply Chain Services through stationed phlebotomy teams at laboratories and hospitals; deployment of skilled laboratory technicians and paramedical staff for internal operations; and specialized inter-state and intra-state logistics services. The company’s logistics solutions ensure temperature-controlled and Turnaround time (TAT) sensitive movement of blood samples and other healthcare products. In addition, the company provides end-to-end phlebotomy services to diagnostic laboratories, doctor
1. Providing Healthcare Logistics Services-NA 2. NA-NA 3. NA-NA 4. NA-NA
1. Providing Healthcare Logistics Services-100%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Molbio Diagnostics Limited | ₹14,676 Cr | 86.2 | — | ₹408 Cr | — |
| Hemant Surgical Industries Lim | ₹825 Cr | 38 | — | — | +87.3% |
| Credent Connect N Care | ₹595 Cr | 23.4 | — | — | — |
| QMS Medical Allied Services Limited | ₹334 Cr | 32.1 | 12.29% | ₹57 Cr | +81.9% |
| Nureca Ltd | ₹296 Cr | 147.1 | 1.11% | ₹59 Cr | -10.4% |
| Earkart Limited | ₹164 Cr | 29.9 | — | ₹0 Cr | -44.4% |
| Avience Biomedicals Limited | ₹138 Cr | 11.6 | 27.86% | — | — |
Listed by market capitalisation. Ratios are shown for context only.
Credent Connect N Care is trading at ₹326.55, with a market capitalisation of ₹595 Cr.
Credent Connect N Care operates in the Health Care > Health Care Equipment and Services > Health Care Equipment and Supplies space (Health Care Equipment > Medical Testing, Analyzing, and Diagnostic Equipment).
Credent Connect N Care has a P/E of 23.4.
Credent Connect N Care is listed on the NSE under the symbol CREDENT.
Data as of 28 Oct 2026. Descriptive market data only — not investment advice.